On entry into the cohort, participants, including both survivors and siblings,
completed a baseline questionnaire that collected basic demographic and
health-related information. For participants under age 18 at baseline, the
questionnaire was completed by a parent or guardian. Follow-up questionnaires
are mailed to participants approximately every two years to update baseline
data and to gather additional information on questions of interest.
In addition to completing the baseline questionnaire, survivors agreed to
release medical records of their cancer treatment; participating centers
provided detailed abstracts of treatment records for all consenting survivors
enrolled in the cohort from their site. Treatment information includes
cumulative dose-specific exposure to chemotherapy, surgical procedures, and
radiation therapy. The latter is evaluated by the radiation physics center
at M.D. Anderson Cancer Center.
| Sex |
|
|
Survivors |
Siblings |
| Males 7,709 |
Males 1,846 |
| Female 6,643 |
Female 2,000 |
| Current age (as of 5/1/2000) |
|
|
Survivors |
Siblings |
|
|
9-15 |
53 |
| 16-20 |
597 |
16-20 |
320 |
| 21-25 |
2,769 |
21-25 |
675 |
| 26-30 |
3,017 |
26-30 |
688 |
| 31-35 |
3.239 |
31-35 |
707 |
| 36-40 |
2,528 |
36-40 |
656 |
| 41-45 |
1,481 |
41-45 |
446 |
| 46-50 |
615 |
46-50 |
229 |
| 51-55 |
106 |
51-55 |
71 |
| Original cancer diagnosis of survivors |
| Leukemia |
4,830 |
| Brain/central nervous system |
1,872 |
| Hodgkin disease |
1,926 |
| Non-Hodgkin lymphoma |
1,082 |
| Kidney |
1,255 |
| Neuroblastoma |
953 |
| Soft-tissue sarcoma |
1,245 |
| Bone |
1,189 |